Atogepant

Atogepant is a compound being investigated for migraine prophylaxis.

Type of Molecule

Small Molecule

Target

CGRP

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
Migraine Prophylaxis US, EU
Phase 3